MA
EW icon

MJP Associates’s Edwards Lifesciences EW Stock Holding History

MJP Associates’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
2,629
+1
+0% +$84 0.03% 196
2026
Q1 		$210K Buy
2,628
+180
+7% +$14.8K 0.03% 218
2025
Q4 		$209K Buy
+2,448
New +$201K 0.03% 234
2024
Q3 		– Sell
-8,590
Closed -$793K – 227
2024
Q2 		$793K Buy
8,590
+340
+4% +$30.1K 0.17% 69
2024
Q1 		$788K Buy
8,250
+2,075
+34% +$174K 0.17% 72
2023
Q4 		$471K Buy
6,175
+83
+1% +$5.78K 0.13% 82
2023
Q3 		$422K Buy
6,092
+295
+5% +$23.7K 0.12% 78
2023
Q2 		$547K Buy
5,797
+763
+15% +$66.3K 0.18% 70
2023
Q1 		$416K Buy
5,034
+329
+7% +$25.9K 0.13% 76
2022
Q4 		$351K Buy
4,705
+171
+4% +$13.2K 0.1% 90
2022
Q3 		$375K Sell
4,534
-116
-2% -$11.2K 0.11% 82
2022
Q2 		$442K Sell
4,650
-339
-7% -$35.1K 0.12% 72
2022
Q1 		$587K Sell
4,989
-409
-8% -$45.9K 0.15% 68
2021
Q4 		$693K Buy
5,398
+921
+21% +$107K 0.21% 66
2021
Q3 		$507K Buy
4,477
+55
+1% +$6.28K 0.17% 72
2021
Q2 		$458K Sell
4,422
-42
-0.9% -$3.96K 0.15% 77
2021
Q1 		$373K Buy
4,464
+377
+9% +$31.9K 0.15% 82
2020
Q4 		$373K Buy
+4,087
New +$339K 0.16% 79

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

MJP Associates's EW Position: Q2 2026 in Review

MJP Associates increased its Edwards Lifesciences (EW) stake by 0.04% in Q2 2026, buying an estimated $84 and bringing the position to 2,629 shares worth $238K. The position accounts for 0.03% of the portfolio, ranked #196.

MJP Associates first reported a position in EW in Q4 2020 and has held it in 18 quarters since. The position peaked at $793K in Q2 2024. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • MJP Associates held 2,629 shares of Edwards Lifesciences worth $238K as of Q2 2026.
  • MJP Associates bought 1 Edwards Lifesciences share in Q2 2026, an estimated $84.
  • Edwards Lifesciences made up 0.03% of MJP Associates's portfolio in Q2 2026, its #196 holding.
  • MJP Associates first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 18 quarters since.
  • MJP Associates's Edwards Lifesciences position peaked at $793K in Q2 2024.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on MJP Associates's 13F filing for Q2 2026, filed 11 Aug 2026.